CARE STRATEGIES CARRIED OUT BY AN INTENSIVE CARE TEAM FOR PATIENTS DIAGNOSED WITH ARDS

Abstract

Acute Respiratory Distress Syndrome (ARDS) results from lung failure due to primary alveolar ventilation and is exacerbated by a number of risk factors, particularly those affecting young infants (LBW). To review the available clinical evidence on the management of acute respiratory distress syndrome in critically ill infants to provide evidence- and experience-based clinical recommendations for the management of patients with ARDS. This study is a review of the Nursing Database for the Management of Acute Respiratory Distress Syndrome in Premature Babies (BDENF), Scientific Electronic Library Online (SCIELO), PubMed and Latin American and Caribbean Literature in Health Sciences (LILACS ). The goal of modern ARDS management is to increase newborn survival through methods and guidelines and to reduce ARDS complications. US and European guidelines recommend early application of non-invasive ventilation (NIV) to treat breathing difficulties in premature infants to improve outcomes. Continuous respiratory support is one of the pillars of the treatment of ARDS in newborns, and it is worth highlighting that the administration of exogenous surfactants contributed to the survival of these infants. In summary, important issues need to be addressed to improve the management and outcomes of ARDS in preterm infants. Surfactant therapy plays an important role in the treatment of ARDS because it improves survival and reduces pneumothorax.